CHARLES SCHWAB INVESTMENT MANAGEMENT INC - AURA BIOSCIENCES INC ownership

AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 60 filers reported holding AURA BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of AURA BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$652,325
-27.4%
72,7230.0%0.00%
Q2 2023$898,129
+52.6%
72,723
+14.7%
0.00%
Q1 2023$588,473
+17.2%
63,413
+32.6%
0.00%
Q4 2022$501,974
-41.1%
47,807
+1.7%
0.00%
Q3 2022$852,000
+39.7%
47,003
+9.3%
0.00%
Q2 2022$610,000
+79.9%
43,009
+179.7%
0.00%
Q1 2022$339,000
+68.7%
15,379
+30.1%
0.00%
Q4 2021$201,00011,8220.00%
Other shareholders
AURA BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 3,039,892$51,617,00012.92%
Matrix Capital Management Company, LP 4,112,870$69,837,0000.78%
Rock Springs Capital Management LP 1,008,114$17,118,0000.40%
Nantahala Capital Management 99,146$1,683,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,255,480$21,318,0000.04%
Citadel Advisors 2,315,102$37,318,0000.01%
CAAS CAPITAL MANAGEMENT LP 10,000$170,0000.00%
Concord Wealth Partners 150$3,0000.00%
Allianz Asset Management GmbH 55,145$936,0000.00%
FMR LLC 471,300$8,003,0000.00%
View complete list of AURA BIOSCIENCES INC shareholders